{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:54:00Z","timestamp":1789894440572,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T00:00:00Z","timestamp":1404259200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00296-014-3072-5","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T05:27:04Z","timestamp":1404278824000},"page":"233-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Sj\u00f6gren\u2019s syndrome: still not fully understood disease"],"prefix":"10.1007","volume":"35","author":[{"given":"Maria","family":"Ma\u015bli\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Przygodzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brygida","family":"Kwiatkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Sikorska-Siudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,2]]},"reference":[{"issue":"4","key":"3072_CR1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2011.10.002","volume":"11","author":"P Cruz-Tapias","year":"2012","unstructured":"Cruz-Tapias P, Rojas-Villarraga A, Maier-Moore S, Anaya JM (2012) HLA and Sj\u00f6gren\u2019s syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun Rev 11(4):281\u2013287","journal-title":"Autoimmun Rev"},{"key":"3072_CR2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.berh.2012.01.012","volume":"26","author":"Y Peri","year":"2012","unstructured":"Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y (2012) Sj\u00f6gren\u2019s syndrome, the old and the new. Best Pract Clin Rheum 26:105\u2013117","journal-title":"Best Pract Clin Rheum"},{"issue":"4","key":"3072_CR3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0889-857X(05)70177-0","volume":"26","author":"EO Johnson","year":"2000","unstructured":"Johnson EO, Skopouli FN, Moutsopoulos HM (2000) Neuroendocrine manifestations in Sj\u00f6gren\u2019s syndrome. Rheum Dis Clin North Am 26(4):927\u2013949","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"3072_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000135622","volume":"15","author":"AG Tzioufas","year":"2008","unstructured":"Tzioufas AG, Tsonis J, Moutsopoulos HM (2008) Neuroendocrine dysfunction in Sjogren\u2019s syndrome. NeuroImmunoModulation 15(1):37\u201345","journal-title":"NeuroImmunoModulation"},{"issue":"6","key":"3072_CR5","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/rheumatology\/ker448","volume":"51","author":"A Bikker","year":"2002","unstructured":"Bikker A, Moret FM, Kruize AA, Bijlsma JW, Lafeber FP, van Roon (2002) IL-7 drives Th1 and Th17 cytokine production in patients with primary SS despite an increase in CD4 T cells lacking the IL-7R\u03b1. Rheumatology (Oxford) 51(6):996\u20131005","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"3072_CR6","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/rheumatology\/kes435","volume":"52","author":"F Ciccia","year":"2013","unstructured":"Ciccia F, Alessandro R, Rodolico V et al (2013) IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren\u2019s syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes. JA Rheumatology (Oxford) 52(6):1009\u20131017","journal-title":"JA Rheumatology (Oxford)"},{"issue":"5","key":"3072_CR7","doi-asserted-by":"crossref","first-page":"R179","DOI":"10.1186\/ar3504","volume":"13","author":"KY Kang","year":"2011","unstructured":"Kang KY, Kim HO, Kwok SK, Ju JH et al (2011) Impact of interleukin-21 in the pathogenesis of primary Sj\u00f6gren\u2019s syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands. Arthritis Res Ther 13(5):R179. doi: 10.1186\/ar3504.Epub","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3072_CR8","doi-asserted-by":"crossref","first-page":"R170","DOI":"10.1186\/ar3493","volume":"13","author":"K Yoshimoto","year":"2011","unstructured":"Yoshimoto K, Tanaka M, Kojima M, Setoyama Y, Kameda H, Suzuki K, Tsuzaka K, Ogawa Y, Tsubota K, Abe T, Takeuchi T (2011) Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sj\u00f6gren\u2019s syndrome. Arthritis Res Ther 13(5):R170","journal-title":"Arthritis Res Ther"},{"key":"3072_CR9","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/ar4442","volume":"16","author":"D Cornec","year":"2014","unstructured":"Cornec D, Saraux A, Pers JO et al (2014) Diagnostic occuracy of blood B-cell subset profiling and autoimmunity markers in Sjogren\u2019s syndrome. Arthritis Res Ther 16:R15","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"3072_CR10","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.4049\/jimmunol.167.7.3610","volume":"167","author":"J\u00d8 Bohnhorst","year":"2001","unstructured":"Bohnhorst J\u00d8, Bj\u00f8rgan MB, Thoen JE, Natvig JB, Thompson KM (2001) Bm1\u2013Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sj\u00f6gren\u2019s syndrome. Immunology 167(7):3610\u20133618","journal-title":"Immunology"},{"key":"3072_CR11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/ar3348","volume":"13","author":"P Youinou","year":"2011","unstructured":"Youinou P, Pers JO (2011) Disturbance of cytokine networks in Sj\u00f6gren\u2019s syndrome. Arthritis Res Ther 13:227","journal-title":"Arthritis Res Ther"},{"key":"3072_CR12","doi-asserted-by":"crossref","unstructured":"Baldini C, Delle Sedie A, Luciano N, Pepe P, Ferro F, Talarico R, Tani C, Mosca M (2013) Vitamin D in \u201cearly\u201d primary Sj\u00f6gren\u2019s syndrome: does it play a role in influencing disease phenotypes? Rheumatol Int. doi: 10.1007\/s00296-013-2872-3","DOI":"10.1007\/s00296-013-2872-3"},{"issue":"3","key":"3072_CR13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jaut.2012.05.018","volume":"39","author":"N Agmon-Levin","year":"2012","unstructured":"Agmon-Levin N, Kivity S, Tzioufas AG et al (2012) Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sj\u00f6gren\u2019s syndrome. J Autoimmun 39(3):234\u2013239","journal-title":"J Autoimmun"},{"key":"3072_CR14","unstructured":"Kyriakidis NC, Kapsogeorgou EK, Tzioufas AG (2003) A comprehensive review of autoantibodies in primary Sjogren\u2019s syndrome: clinical phenotypes and regulatory mechanisms. J Autoimmun 51C:67\u201374"},{"key":"3072_CR15","doi-asserted-by":"crossref","unstructured":"Sumida T, Tsuboi H, Iizuka M, Hirota T, Asashima H, Matsumoto I (2014) The role of M3 muscarinic acetylcholine receptor reactive T cells in Sj\u00f6gren\u2019s syndrome: a critical review. J Autoimmun (4). doi: 10.1016\/j.jaut.2013.12.012","DOI":"10.1016\/j.jaut.2013.12.012"},{"issue":"9 Pt 2","key":"3072_CR16","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1016\/j.lpm.2012.05.019","volume":"41","author":"T Sumida","year":"2012","unstructured":"Sumida T, Lizuka M, Asashima H, Tsuboi H, Matsumoto I (2012) Pathogenic role of anti-M3 muscarinic acetylcholine receptor immune response in Sj\u00f6gren\u2019s syndrome. Presse Med 41(9 Pt 2):e461\u2013e466","journal-title":"Presse Med"},{"key":"3072_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-230X-2-21","volume":"2","author":"MJ Kaplan","year":"2002","unstructured":"Kaplan MJ, Ike RW (2002) The liver is a common non-exocrine target in primary Sj\u00f6gren\u2019s syndrome: a retrospective review. BMC Gastroenterol 2:21","journal-title":"BMC Gastroenterol"},{"key":"3072_CR18","unstructured":"Karp JK, Akpek EK, Anders RA (2010) Autoimmune hepatitis in patients with primary Sj\u00f6gren\u2019s syndrome: a series of two-hundred and two patients. Int J Clin Exp Pathol 25;3(6):582\u20136"},{"issue":"3","key":"3072_CR19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0923-1811(99)00032-8","volume":"21","author":"M Ono","year":"1999","unstructured":"Ono M, Ono M, Watanabe K, Miyashita Y et al (1999) A study of anti-carbonic anhydrase II antibodies in rheumatic autoimmune diseases. J Dermatol Sci 21(3):183\u2013186","journal-title":"J Dermatol Sci"},{"issue":"3","key":"3072_CR20","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/ar2420","volume":"10","author":"F Atzeni","year":"2008","unstructured":"Atzeni F, Sarzi-Puttini P, Lama N et al (2008) Anti-cyclic citrullinated peptide antibodies in primary Sjogren syndrome may be associated with non-erosive synovitis. Arthritis Res Ther 10(3):R51","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"3072_CR21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clim.2012.09.013","volume":"145","author":"L Shen","year":"2012","unstructured":"Shen L, Suresh L, Lindemann M et al (2012) Novel autoantibodies in Sjogren\u2019s syndrome. Clin Immunol 145(3):251\u2013255","journal-title":"Clin Immunol"},{"issue":"6","key":"3072_CR22","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/art.11460","volume":"49","author":"F D\u2019Arbonneau","year":"2003","unstructured":"D\u2019Arbonneau F, Ansart S, Le Berre R, Dueymes M, Youinou P, Pennec YL (2003) Thyroid dysfunction in primary Sj\u00f6gren\u2019s syndrome: a long-term followup study. Arthritis Rheum 49(6):804\u2013809","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3072_CR23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/ard.2003.010058","volume":"63","author":"R Tunc","year":"2004","unstructured":"Tunc R, Gonen M, Acbay O, Hamuryudan V, Yazici H (2004) Autoimmune thyroiditis and anti-thyroid antibodies in primary Sj\u00f6gren\u2019s syndrome: a case\u2013control study. Ann Rheum Dis 63(5):575\u2013577","journal-title":"Ann Rheum Dis"},{"key":"3072_CR24","doi-asserted-by":"crossref","unstructured":"Shiboski SC, Shiboski CH, Criswell L et al (2012) American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) A;64(4):475\u201387","DOI":"10.1002\/acr.21591"},{"key":"3072_CR25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2012-202565","volume":"72","author":"C Vitali","year":"2013","unstructured":"Vitali C, Bootsma H, Bowman SJ et al (2013) Classification criteria for Sj\u00f6gren\u2019s syndrome: we actually need to definitively resolve the long debate on the issue. Ann Rheum Dis 72:476\u2013478","journal-title":"Ann Rheum Dis"},{"key":"3072_CR26","doi-asserted-by":"crossref","unstructured":"Rasmussen A, Ice JA, Li H et al (2014) Comparison of the American-European Consensus Group Sj\u00f6gren\u2019s syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterized sicca cohort. Ann Rheum Dis 73(1). doi: 10.1136\/annrheumdis-2013-203845","DOI":"10.1136\/annrheumdis-2013-203845"},{"key":"3072_CR27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/ard.51.4.499","volume":"52","author":"PM Speight","year":"1992","unstructured":"Speight PM, Kaul A, Melsom RD et al (1992) Measurement of whole unstimulated salivary flow in the diagnosis of Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 52:499\u2013502","journal-title":"Ann Rheum Dis"},{"key":"3072_CR28","doi-asserted-by":"crossref","unstructured":"Theander E, Mandl T. (2013) Primary sjogrens syndrome : the diagnostic and prognostic value of salivary gland ultrasonography using simplified scoring system. Arthritis Care Res (Hoboken) 10. doi: 10.1002\/acr.22264","DOI":"10.1002\/acr.22264"},{"issue":"6","key":"3072_CR29","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/rheumatology\/keh588","volume":"44","author":"A Hocevar","year":"2005","unstructured":"Hocevar A, Amrozic A, Rozman B, Kveder T, Tomsic M (2005) Ultrasonographic changes of major salivary glands in primary Sjogren\u2019s syndrome. Diagnostic value of the novel scoring system. Rheumatology (Oxford) 44(6):768\u2013772","journal-title":"Rheumatology (Oxford)"},{"key":"3072_CR30","doi-asserted-by":"crossref","unstructured":"Varela-Centelles P, Seoane-Romero JM, S\u00e1nchez-S\u00e1nchez M, Gonz\u00e1lez-Mosquera A, Diz-Dios P, Seoane J (2014) Minor salivary gland biopsy in Sj\u00f6gren\u2019s syndrome: a review and introduction of a new tool to ease the procedure. Med Oral Patol Oral Cir Bucal 1;19(1):e20\u2013e23","DOI":"10.4317\/medoral.19131"},{"issue":"5","key":"3072_CR31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.reuma.2012.03.006","volume":"8","author":"M Lida Santiago","year":"2012","unstructured":"Lida Santiago M, Seisdedos MR, Garc\u00eda Salinas RN et al (2012) Frequency of complications and usefulness of the minor salivary gland biopsy. Reumatol Clin 8(5):255\u2013258 Epub 2012 Jul 6","journal-title":"Reumatol Clin"},{"issue":"8","key":"3072_CR32","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/ard.2010.144782","volume":"70","author":"E Theander","year":"2011","unstructured":"Theander E, Vasaitis L, Baecklund E et al (2011) Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 70(8):1363\u20131368","journal-title":"Ann Rheum Dis"},{"key":"3072_CR33","unstructured":"Okazaki K, Umehara H (2012) Are classification criteria for IgG4-RD now possible? The concept of IgG4 related diseases and proposal of comprehensive diagnostic criteria in Japan. Int J Rheum. doi: 10.1155\/2012\/357971"},{"issue":"2","key":"3072_CR34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.md.0000157397.30055.c9","volume":"84","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Loustaud-Ratti V, De Vita S, Zeher M, Bosch JA, Toussirot E, Medina F, Rosas J, Anaya JM, Font J, SS-HCV Study Group (2005) Sj\u00f6gren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 84(2):81\u201399","journal-title":"Medicine (Baltimore)"},{"key":"3072_CR35","first-page":"299","volume":"63","author":"K Madali\u0144ski","year":"2009","unstructured":"Madali\u0144ski K, Godzik P, Zimmermann-G\u00f3rska I et al (2009) Anti-HCV and HCV-RNA in patients with primary Sjogren\u2019s syndrome. Przegl Epidemiol 63:299\u2013304","journal-title":"Przegl Epidemiol"},{"issue":"8","key":"3072_CR36","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","volume":"42","author":"M Voulgarelis","year":"1999","unstructured":"Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM (1999) Malignant lymphoma in primary Sj\u00f6gren\u2019s syndrome: a multicenter, retrospective, clinical study by the European concerted action on Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 42(8):1765\u20131772","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3072_CR37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","volume":"88","author":"E Baimpa","year":"2009","unstructured":"Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM (2009) Hematologic manifestations and predictors of lymphoma development in primary Sj\u00f6gren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 88(5):284\u2013293","journal-title":"Medicine (Baltimore)"},{"key":"3072_CR38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.semcancer.2013.11.005","volume":"24","author":"C Thiebelmont","year":"2013","unstructured":"Thiebelmont C, Bertoni F, Copie-Bergman C, Ferreri AJM, Ponzoni M (2013) Chronic inflammation and extra-nodal-zone lymphomas of MALT-type. Semin Cancer Biol 24:33\u201342","journal-title":"Semin Cancer Biol"},{"key":"3072_CR39","doi-asserted-by":"crossref","unstructured":"Quartuccio L, Isola M, Baldini Ch et al (2013) Biomarkers of lymphoma in Sjogren\u2019s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. J Autoimmun 1\u20136. doi: 10.1016\/j.jaut.2013.10.002","DOI":"10.1016\/j.jaut.2013.10.002"},{"key":"3072_CR40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcancer.2013.12.001","volume":"24","author":"E Baecklund","year":"2014","unstructured":"Baecklund E, Smedbyb KE, Suttonc LA, Askling J, Rosenquist R (2014) Lymphoma development in patients with autoimmune and inflammatory disorders\u2014what are the driving forces? Semin Cancer Biol 24:61\u201370","journal-title":"Semin Cancer Biol"},{"key":"3072_CR41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jama.2010.1014","volume":"304","author":"L Barclay","year":"2010","unstructured":"Barclay L (2010) Treatment of primary Sjogren\u2019s syndrome reviewed. JAMA 304:452\u2013460","journal-title":"JAMA"},{"issue":"4","key":"3072_CR42","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.27314","volume":"62","author":"JM Meijer","year":"2010","unstructured":"Meijer JM, Meiners PM, Vissink A et al (2010) Effectivnes of Rituximab treatment in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 62(4):960\u2013968","journal-title":"Arthritis Rheum"},{"key":"3072_CR43","doi-asserted-by":"crossref","unstructured":"Mariette X, Seror R, Quartuccio L et al (2013) Efficacy and safety of belimumab in primary Sj\u00f6gren\u2019s syndrome: results of BELLIS open label phase II study. Ann Rheum Dis 1\u20136. doi: 10.1136\/annrheumdis-2013-203991","DOI":"10.1136\/annrheumdis-2013-203991"},{"key":"3072_CR44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2249.2009.03979.x","volume":"157","author":"MC Levasque","year":"2009","unstructured":"Levasque MC (2009) Translational mini-review series on B cell-directed the rapies: recent advances in B cell-directed biological therapies for autoimmune disorders. Clin Exp Immun 157:198\u2013208","journal-title":"Clin Exp Immun"},{"issue":"4","key":"3072_CR45","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1186\/ar2018","volume":"8","author":"SD Steinfeld","year":"2006","unstructured":"Steinfeld SD, Tant L, Burmester GR et al (2006) Epratuzumab (humanised anti-CD22 antibody) in primary Sj\u00f6gren\u2019s syndrome: an open-label phase I\/II study. Arthritis Res Ther 8(4):R129","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3072_CR46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2249.2011.04460.x","volume":"167","author":"A Vossenk\u00e4mper","year":"2012","unstructured":"Vossenk\u00e4mper A, Lutalo PM, Spencer J (2012) Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome: clinical implications and effects of B cell-targeted therapies. Clin Exp Immunol 167(1):7\u201314","journal-title":"Clin Exp Immunol"},{"key":"3072_CR47","doi-asserted-by":"crossref","unstructured":"Xu J, Wang D, Liu D, Fan Z et al (2012) Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sj\u00f6gren syndrome. Blood 11;120(15):3142\u201351","DOI":"10.1182\/blood-2011-11-391144"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-014-3072-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3072-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3072-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T09:26:13Z","timestamp":1565601973000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-014-3072-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["3072"],"URL":"https:\/\/doi.org\/10.1007\/s00296-014-3072-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,2]]}}}